Positron emission tomography and positron emission tomography-CT evaluation for recurrent papillary thyroid carcinoma: meta-analysis and literature review.
meta_analysis · Level I
Where this comes from
- Record sourced from PubMed, PMID 20665734.
- Also identified by DOI 10.1002/hed.21492.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Sensitivity and specificity data regarding positron emission tomography (PET) and PET/CT for surveillance of well-differentiated thyroid cancer does not evaluate subtypes separately. Papillary and follicular thyroid carcinoma may have different characteristics on PET/CT imaging and so should be investigated individually. This is a systematic meta-analysis of studies using PET for surveillance in patients with papillary thyroid carcinoma. Using different statistical models, combined sensitivity of PET and PET/CT for papillary thyroid carcinoma was 77% by the fixed effect model and 82% by the random-effects model, specificity was calculated as 85% and 84%, respectively. Meta-regression was performed to evaluate whether I-131 negativity affected PET positivity; no correlation between I-131 negativity and PET sensitivity or specificity was found. PET and PET/CT are useful modalities in surveillance of papillary thyroid carcinoma. To our knowledge, this is the first study to examine papillary thyroid carcinoma independently of other subtypes of well-differentiated thyroid carcinoma.
Medical subject headings
- Carcinoma, Papillary
- Neoplasm Recurrence, Local
- Positron-Emission Tomography
- Thyroid Neoplasms
- Tomography, X-Ray Computed